Adamax

Adamax

Adamax is a research-grade synthetic neuropeptide derived from the ACTH(4-7) sequence, developed for preclinical investigation of neurotrophic signalling and neuroprotection. It has been studied in experimental models for its effects on brain-derived neurotrophic factor (BDNF) expression, neuronal survival, and synaptic plasticity. It represents a distinct compound in the neuropeptide research space with a well-characterised mechanism and a growing body of preclinical literature.

Mechanism of Action

Adamax has been studied in preclinical models for its effects on BDNF and nerve growth factor (NGF) expression in the central nervous system, and its modulation of serotonergic and dopaminergic neurotransmission. It has been investigated for its effects on synaptic plasticity and neuronal resilience in research settings, and is a subject of interest for studies on non-sedating neuroprotection.

Research Applications

• BDNF and NGF expression and neurotrophin signalling research
• Synaptic plasticity and neuronal survival investigation
• Serotonergic and dopaminergic neurotransmission modelling
• Neuronal signalling pathway investigation
• HPA axis and neuroendocrine signalling studies

Specifications

• Molecular Formula: C₅₀H₆₉N₁₁O₁₁S
• CAS Number: 80714-61-0
• Purity: ≥98%
• Molecular Weight: 1032.23 g/mol
• Form: Lyophilised powder
• Storage: -20°C
• Shelf Life: 24 months

This product is intended for legitimate laboratory and analytical research use only. Not for human use, veterinary use, or consumer use. Not for diagnostic or therapeutic purposes.